Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas

被引：0

作者：

Fardella, E. ^{[1
]}

Zanirato, G. ^{[2
]}

Magni, M. ^{[2
]}

Caldarelli, N. ^{[1
]}

Chiappella, A. ^{[2
]}

Dodero, A. ^{[2
]}

Ljevar, S. ^{[3
]}

Orsucci, L. ^{[4
]}

Re, A. ^{[5
]}

Usai, S. V. ^{[6
]}

Stefoni, V. ^{[7
]}

Castellino, C. ^{[8
]}

Rossi, F. G. ^{[9
]}

Pinto, A. ^{[10
]}

Carniti, C. ^{[2
]}

Corradini, P. ^{[1
,2
]}

机构：

[1] Univ Milan, Milan, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Div Hematol & Stem Cell Transplantat, Milan, Italy

[3] Fdn IRCCS Ist Nazl Tumori, Unit Biostat Clin Res, Milan, Italy

[4] Azienda Osped & Univ Citta Salute & Sci, Div Hematol, Turin, Italy

[5] ASST Spedali Civili Brescia, Hematol Div, Brescia, Italy

[6] Osped Oncol Armando Businco, Hematol Unit, Cagliari, Italy

[7] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy

[8] Azienda Osped S Croce & Carle, Div Hematol, Cuneo, Italy

[9] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Div Hematol, Milan, Italy

[10] Fdn G Pascale, IRCCS Ist Nazl Tumori, Hematol Oncol & Stem Cell Transplantat Unit, Naples, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2024年 / 204卷 / 05期

关键词：

DNA prognosis; haematological malignancies; prognostic factors; T-cell lymphoma; CANCER;

D O I：

10.1111/bjh.19280

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Peripheral T-cell lymphomas (PTCLs) have a poor prognosis and, to date, there are no reliable predictive biomarkers of response. In this work we explored the prognostic impact of cell-free DNA (cfDNA) concentration in 75 newly diagnosed patients enrolled in a prospective multicenter study. Pre-treatment cfDNA was strongly associated with clinical risk factors and was identified as a superior predictor for shorter progression-free survival in multivariable analysis, outweighing canonical risk parameters. Furthermore, we identified a cfDNA value above which survival worsens. In conclusion, pre-treatment cfDNA concentration represents an easily usable predictive biomarker that is highly associated with survival of PTCL patients.

引用

页码：1752 / 1756

页数：5

共 50 条

[31] Bexarotene in Patients With Peripheral T-cell Lymphomas: Results of a Retrospective Study
Farhan, Ahmed
Chong, Elise A.
Schuster, Stephen J.
Strelec, Lauren
Nasta, Sunita Dwivedy
Landsburg, Daniel
Svoboda, Jakub
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (02) : 109 - 115
[32] The Impact of Cell-Free DNA Analysis on the Management of Retinoblastoma
Gerrish, Amy
Jenkinson, Helen
Cole, Trevor
CANCERS, 2021, 13 (07)
[33] Cell-Free DNA As Peripheral Biomarker of Alzheimer's Disease
Khemka, Sachi
Sehar, Ujala
Manna, Pulak R.
Kshirsagar, Sudhir
Reddy, P. Hemachandra
AGING AND DISEASE, 2024, : 787 - 803
[34] Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Dogs With Tumors
Kim, Jihu
Bae, Hyeona
Ahn, Soomin
Shin, Sunwoo
Cho, ARom
Cho, Kyu-Woan
Jung, Dong-In
Yu, DoHyeon
FRONTIERS IN VETERINARY SCIENCE, 2021, 8
[35] Prognostic Significance of Peripheral T-Cell Subsets in Laryngeal Squamous Cell Carcinoma
Marchi, Filippo
Missale, Francesco
Incandela, Fabiola
Filauro, Marta
Mazzola, Francesco
Mora, Francesco
Paderno, Alberto
Parrinello, Giampiero
Piazza, Cesare
Peretti, Giorgio
LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2019, 4 (05): : 513 - 519
[36] Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma
Oki, Yasuhiro
Younes, Anas
Copeland, Amanda
Hagemeister, Fredrick
Fayad, Luis E.
McLaughlin, Peter
Shah, Jatin
Fowler, Nathan
Romaguera, Jorge
Kwak, Larry W.
Pro, Barbara
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 138 - 141
[37] Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
Shyr, Bor-Uei
Shyr, Bor-Shiuan
Chen, Shih-Chin
Chang, Shih-Ching
Shyr, Yi-Ming
Wang, Shin-E
CANCERS, 2021, 13 (10)
[38] Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas
Ngu, Henry S.
Savage, Kerry J.
REVISTA CHILENA DE LITERATURA, 2023, (108): : 3211 - 3226
[39] Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas
Ngu, Henry S.
Savage, Kerry J.
HAEMATOLOGICA, 2023, 108 (12) : 3211 - 3226
[40] Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) versus CHOP in newly diagnosed peripheral T-cell lymphoma patients
Sun, Yuanyuan
Li, Ling
Li, Xin
Zhang, Lei
Wang, Xinhua
Fu, Xiaorui
Sun, Zhenchang
Zhang, Xudong
Li, Zhaoming
Wu, Jingjing
Yu, Hui
Chang, Yu
Yan, Jiaqin
Wu, Xiaolong
Zhou, Zhiyuan
Nan, Feifei
Tian, Li
Zhang, Mingzhi
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12

← 1 2 3 4 5 →